Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.12 +0.05 (+1.60%)
As of: Oct 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (EOCN) Current Debt (2013 - 2020)

Updated

Galmed Pharmaceuticals' Current Debt was $37,000 in Q1 2020, compared with -$199,000 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Current Debt (2013 - 2020) Analysis & Trends

On a trailing twelve-month basis, Galmed Pharmaceuticals' Current Debt was -$262,000 through Mar 31, 2020; for FY2012, it came in at $26,000.

  • The Q1 2020 figure marks the highest quarterly Current Debt since Q1 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Galmed Pharmaceuticals 1.68 Mn -39.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 37,000.00
Mar 31, 2019 -199,000.00
Mar 31, 2014 26,000.00
Dec 31, 2013 -40,000.00
Mar 31, 2013 20,000.00
API Access

Galmed Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=EOCN&period=max&api_key=YOUR_API_KEY